Efficacy and safety of Shengjiang Xiexin decoction in prophylaxis of chemotherapy-related diarrhea in small cell lung cancer patients: study protocol for a multicenter randomized controlled trial

BACKGROUND: Diarrhea is a common adverse reaction in patients with cancer receiving chemotherapy, for which there is currently no effective method of treatment. Shengjiang Xiexin decoction (SXD), a classic traditional Chinese medicine (TCM) formula, has shown efficacy in alleviating irinotecan-induc...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Chao, Lou, Yanni, Gao, Yu, Deng, Bo, Su, Fei, Jia, Liqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193543/
https://www.ncbi.nlm.nih.gov/pubmed/32357899
http://dx.doi.org/10.1186/s13063-020-04275-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193543/
https://www.ncbi.nlm.nih.gov/pubmed/32357899
http://dx.doi.org/10.1186/s13063-020-04275-5

Ejemplares similares